GMI-1687

N/A

Report date: 2024/04/22 09:55:34
NME

Base Information

Drug NameGMI-1687
Drug Alias NameGMI-1687APL-108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSelectin E inhibitors
TargetsSelectin E
Therapy Area/IndicationsInflammationAnemia, Sickle CellLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCrescent Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesApollomics IncCrescent Biopharma Inc
Inactive CompaniesN/A
Active IndicationsInflammationAnemia, Sickle Cell
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A